Drugs / A51R3
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06329674 Background | Apr 2021 → Dec 2022 | type 2 diabetes mellitus | AJU Pharm Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A51R3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06329674 ↗ |